Atrial fibrillation (AFib) occurs when the heart beats irregularly or too fast and can increase the risk for stroke and heart failure. AFib, however, is hardly consistent. When symptoms come and go, it can be a difficult condition to accurately diagnose.

On-the-go EKGs used in Saint Luke’s heart research

If you have AFib, are currently taking blood thinning medication, and have a smartphone, you may be a candidate for our Better Outcomes of Anticoagulation Treatment by Observation of Atrial Rhythm (BOAT OAR) study.

The advent of accurate smartphone-based heart monitoring applications has made it possible to log heart rhythm irregularities outside of medical facilities. Researchers conducting the BOAT OAR study hypothesize that patients who can easily keep tabs on their heart health will be more likely to stay on their prescribed direct oral anticoagulant (DOAC) or warfarin medications.

Study participants are provided with AliveCor™ Kardia monitors that work with a smartphone to perform real-time EKGs on demand. Participants who receive the monitor must simply use the monitor at least once a day, five times a week for six months. Because symptoms for AFib can be erratic, this technology gives participants comfort and flexibility in knowing diagnosis is literally at their fingertips. By using this device, they can show their physician precisely what they experienced, when, and for how long.

If you’re interested in participating in the BOAT OAR study, contact Tina Baker.

Contact us